Assignee
NAT INST BIOTECHNOLOGY NEGEV LTD
IL·20 granted patents·15 pending applications·13 citations·filing 2015–2025
Top patents by PatentIndex Score
35 records- 0184US10508091B2Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunctionNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2016·Granted Dec 17, 2019·3 cites·7 claims
- 0283US10434099B2Methods for treating central nervous system disorders using VDAC inhibitorsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2017·Granted Oct 8, 2019·2 cites·5 claims
- 0381US11472777B2Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunctionNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2020·Granted Oct 18, 2022·1 cites·8 claims
- 0478US11667700B2Anti-PCNA monoclonal antibodies and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2020·Granted Jun 6, 2023·1 cites·19 claims
- 0578US10787423B2Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunctionNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2019·Granted Sep 29, 2020·1 cites·17 claims
- 0677US11098091B2Compositions and methods for treatment of bone associated diseasesNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2017·Granted Aug 24, 2021·2 cites·7 claims
- 0776US11408887B2Biomarkers for diagnosis of lung cancerNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2018·Granted Aug 9, 2022·1 cites·4 claims
- 0876US2025043000A1Non-cytotoxic modified cells and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2024·Application pending·0 cites
- 0970US10308703B2Variants of DR3 and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2015·Granted Jun 4, 2019·2 cites·10 claims
- 1070US2022170114A1Biomarkers of chronic lymphocytic leukemia and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Application pending·0 cites
- 1169US2023055614A1Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting vdac oligomerization, apoptosis and mitochondria dysfunctionNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Application pending·0 cites
- 1268US11976280B2SMAC/Diablo inhibitors useful for treating cancerNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Granted May 7, 2024·0 cites·14 claims
- 1368US11911443B2Fusion proteins with extended serum half lifeNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2021·Granted Feb 27, 2024·0 cites·18 claims
- 1465US11976099B2Compositions and methods for treatment of bone associated diseasesNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2021·Granted May 7, 2024·0 cites·8 claims
- 1564US10946013B2Methods for treating central nervous system disorders using vdac inhibitorsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2019·Granted Mar 16, 2021·0 cites·20 claims
- 1661US12408637B2Compositions for inoculating aquatic animalsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Granted Sep 9, 2025·0 cites·18 claims
- 1759US2025206843A1Binding molecules specific to human epidermal growth factor receptor 2NAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2023·Application pending·0 cites
- 1858US12098202B2Non-cytotoxic modified cells and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2017·Granted Sep 24, 2024·0 cites·19 claims
- 1958US11286533B2Biomarkers of chronic lymphocytic leukemia and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2016·Granted Mar 29, 2022·0 cites·10 claims
- 2058US2025051409A1MODULATORS OF PHOSPHATIDYLSERlNE DECARBOXYLASE AND USE THEREOFNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Application pending·0 cites
- 2157US10836818B2Anti-PCNA monoclonal antibodies and use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2017·Granted Nov 17, 2020·0 cites·18 claims
- 2256US11141463B2Fusion proteins with extended serum half lifeNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2017·Granted Oct 12, 2021·0 cites·16 claims
- 2356US2023149477A1Methods of improving health of young ruminantsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2021·Application pending·0 cites
- 2455US12544421B2VDAC inhibitors for treating inflammatory bowel diseasesNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2019·Granted Feb 10, 2026·0 cites·7 claims
- 2553US2023270783A1Immune system restoration by cell therapyNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2021·Application pending·0 cites
- 2653US2023066049A1Peptides useful in preservation and/or restoration of functional pancreatic islets and in treating diabetesNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2021·Application pending·0 cites
- 2750US2023063495A1Bacterial populations for desirable traits in ruminating animalsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Application pending·0 cites
- 2848US2022315640A1Tumor environment specific expression of effector genesNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2022·Application pending·0 cites
- 2946US11555192B2SMAC/Diablo inhibitors useful for treating cancerNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2018·Granted Jan 17, 2023·0 cites·8 claims
- 3046US2025312377A1Tumor environment-specific expression of chimeric antigen receptorsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2025·Application pending·0 cites
- 3144US9850294B2IL-17R-ECD mutants and methods of using sameNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2016·Granted Dec 26, 2017·0 cites·20 claims
- 3241US2020231642A1Peptide kinase inhibitors and methods of use thereofNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2018·Application pending·0 cites
- 3341US2022196677A1Kits, compositions and methods for evaluating immune system statusNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2020·Application pending·0 cites
- 3439US2018362616A1VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAINNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2016·Application pending·0 cites
- 3536US2021030799A1Tumor environment-specific expression of chimeric antigen receptorsNAT INST BIOTECHNOLOGY NEGEV LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NAT INST BIOTECHNOLOGY NEGEV LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →